Literature DB >> 7649559

Two further cases of mutation R1947X in the NF1 gene: screening for a relatively common recurrent mutation.

C Lázaro1, H Kruyer, A Gaona, X Estivill.   

Abstract

We present two further cases of mutation R1947X in the neurofibromatosis type 1 gene. To date, a total of nine cases of mutation R1947X have been reported giving a frequency of about 2% and confirming the recurrence of this mutation. R1947X occurs within a CpG dinucleotide and supports the hypothesis that the mutation rate for this dinucleotide is higher than that of other dinucleotides. As routine analysis for R1947X is advisable, we have developed an allele-specific oligonucleotide hybridization assay for the efficient screening of a large number of samples.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7649559     DOI: 10.1007/bf00210425

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  15 in total

1.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

2.  [Mutation processes in the formation of hemoglobin variants].

Authors:  F Vogel; G Röhrborn
Journal:  Humangenetik       Date:  1965

3.  Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.

Authors:  D Viskochil; A M Buchberg; G Xu; R M Cawthon; J Stevens; R K Wolff; M Culver; J C Carey; N G Copeland; N A Jenkins
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

4.  A highly informative CA/GT repeat polymorphism in intron 38 of the human neurofibromatosis type 1 (NF1) gene.

Authors:  C Lázaro; A Gaona; G Xu; R Weiss; X Estivill
Journal:  Hum Genet       Date:  1993-10       Impact factor: 4.132

5.  Recurrence of a nonsense mutation in the NF1 gene causing classical neurofibromatosis type 1.

Authors:  X Estivill; C Lázaro; T Casals; A Ravella
Journal:  Hum Genet       Date:  1991-12       Impact factor: 4.132

6.  Two CA/GT repeat polymorphisms in intron 27 of the human neurofibromatosis (NF1) gene.

Authors:  C Lázaro; A Gaona; X Estivill
Journal:  Hum Genet       Date:  1994-03       Impact factor: 4.132

7.  An Alu polymorphism intragenic to the neurofibromatosis type 1 gene (NF1).

Authors:  G F Xu; L Nelson; P O'Connell; R White
Journal:  Nucleic Acids Res       Date:  1991-07-11       Impact factor: 16.971

8.  Characterization of four mutations in the neurofibromatosis type 1 gene by denaturing gradient gel electrophoresis (DGGE).

Authors:  M C Valero; E Velasco; F Moreno; C Hernández-Chico
Journal:  Hum Mol Genet       Date:  1994-04       Impact factor: 6.150

9.  Genomic organization of the neurofibromatosis 1 gene (NF1).

Authors:  Y Li; P O'Connell; H H Breidenbach; R Cawthon; J Stevens; G Xu; S Neil; M Robertson; R White; D Viskochil
Journal:  Genomics       Date:  1995-01-01       Impact factor: 5.736

10.  Nonsense mutations at Arg-1947 in two cases of familial neurofibromatosis type 1 in Japanese.

Authors:  T Horiuchi; N Hatta; M Matsumoto; H Ohtsuka; F S Collins; Y Kobayashi; S Fujita
Journal:  Hum Genet       Date:  1994-01       Impact factor: 4.132

View more
  3 in total

1.  Clinical and molecular characteristics of thirty NF1 variants in Chinese patients with neurofibromatosis type 1.

Authors:  Wen Wang; Weibing Qin; Hongsong Ge; Xiangsheng Kong; Chao Xie; Yunge Tang; Ming Li
Journal:  Mol Biol Rep       Date:  2019-06-14       Impact factor: 2.316

2.  Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo.

Authors:  Sara H Osum; Alexander W Coutts; Dylan J Duerre; Barbara R Tschida; Mark N Kirstein; James Fisher; W Robert Bell; Oona Delpuech; Paul D Smith; Brigitte C Widemann; Christopher L Moertel; David A Largaespada; Adrienne L Watson
Journal:  Neurooncol Adv       Date:  2021-02-10

3.  Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1.

Authors:  Sara H Isakson; Anthony E Rizzardi; Alexander W Coutts; Daniel F Carlson; Mark N Kirstein; James Fisher; Jeremie Vitte; Kyle B Williams; G Elizabeth Pluhar; Sonika Dahiya; Brigitte C Widemann; Eva Dombi; Tilat Rizvi; Nancy Ratner; Ludwine Messiaen; Anat O Stemmer-Rachamimov; Scott C Fahrenkrug; David H Gutmann; Marco Giovannini; Christopher L Moertel; David A Largaespada; Adrienne L Watson
Journal:  Commun Biol       Date:  2018-10-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.